Your browser doesn't support javascript.
loading
Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications.
Vaziri, Zahra; Saleki, Kiarash; Aram, Cena; Alijanizadeh, Parsa; Pourahmad, Ramtin; Azadmehr, Abbas; Ziaei, Naghmeh.
Afiliação
  • Vaziri Z; Student Research Committee, Babol University of Medical Sciences, Babol, Iran; USERN Office, Babol University of Medical Sciences, Babol, Iran.
  • Saleki K; Student Research Committee, Babol University of Medical Sciences, Babol, Iran; USERN Office, Babol University of Medical Sciences, Babol, Iran; Department of e-Learning, Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
  • Aram C; Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
  • Alijanizadeh P; Student Research Committee, Babol University of Medical Sciences, Babol, Iran; USERN Office, Babol University of Medical Sciences, Babol, Iran.
  • Pourahmad R; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Azadmehr A; Immunology Department, Babol University of Medical Sciences, Babol, Iran.
  • Ziaei N; Clinical Research Development unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran; Department of Cardiology, Babol University of Medical Sciences, Babol, Iran. Electronic address: Ziaiexn@yahoo.com.
Biomed Pharmacother ; 168: 115686, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37839109

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Antineoplásicos Limite: Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Antineoplásicos Limite: Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: França